Search

1. COVID-19: urgent federal actions to accelerate America's response

Publication:

Washington, D.C. : Bipartisan Policy Center, January 2021

Subject(s):

COVID-19 -- prevention & control
COVID-19 Testing
COVID-19 Vaccines -- supply & distribution
Healthcare Disparities
United States

2. Policy for coronavirus disease-2019 tests during the public health emergency (revised): immediately in effect guidance for clinical laboratories, commercial manufacturers, and Food and Drug Administration staff

Publication:

[Silver Spring, MD] : Center for Devices and Radiological Health, May 11, 2020

Subject(s):

Clinical Laboratory Techniques
COVID-19 Serological Testing
COVID-19 Testing
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

3. Medicare Part B spending on lab tests increased in 2021, driven by higher volume of COVID-19 tests, genetic tests, and chemistry tests

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022

Subject(s):

Clinical Chemistry Tests
COVID-19 Testing
Genetic Testing
Government Regulation
Medicare Part B -- economics
United States

4. FDA’s work with the tri-agency task force for emergency diagnostics helped labs implement COVID-19 tests

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

Advisory Committees
COVID-19 Testing
Government Agencies
Government Regulation
Laboratories
United States
United States. Food and Drug Administration

5. FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022

Subject(s):

COVID-19 Testing
Device Approval
Government Regulation
United States
United States. Food and Drug Administration